May 18-20, 2021 | VIRTUAL EVENT

Pharmaceuticals, medical device and life science organizations of all sizes have executed digital initiatives at a greater scale in 2020, and continuing through 2021. Marketers do a good job showing how channels reach customers with leading KPIs, but how good a job are we doing demonstrating and actually measuring the impact of digital initiatives on business, especially across channels?

There are many KPIs and channels that can be utilized. However, if senior leadership is not asking the right questions – it becomes increasingly difficult to understand where to make investments or deliver commercial transformation to actually deliver and measure ROI.

Today, there are more questions than answers:

  • What are the shortfalls, and are there more strategic analytical roadmaps for success as an industry?
  • Is omnichannel driving business impact in a more virtual environment? Does it vary across therapeutic areas and specialties?
  • How can we measure/track success as the channel mix changes over time as part of a more advanced attribution model?
  • Does ‘digital’ need to be de-siloed and experts redistributed across commercial functions?
  • Ultimately, how can the industry look to weather change in digital in this time of flux?

Following the resounding success of the inaugural Re:Imagine Pharma Marketing – at the 2nd Re:Imagine Pharma Marketing, this unique event will provide a detailed view on these crucial supporting elements surrounding launching new digital programs to ensure adoption and excellence in execution from all stakeholders at your organization. Through case studies and planning strategy, you will leave this groundbreaking virtual event  with a more holistic internal view of driving innovation that can be applied to any new digital initiative.

SPEAKER HIGHLIGHTS

Robert Allen
Robert Allen
Lead, Worldwide Engagement and Channel Planning, U.S. Oncology - BRISTOL MYERS SQUIBB
Leo Barella
Leo Barella
Vice President, Chief Technology Officer - TAKEDA
Dina Bedier
Dina Bedier
Executive Director, Global Product Owner of Channel Enablement - NOVARTIS
Fred Bennett
Fred Bennett
Executive Director, Digital Strategy and Operations - BAYER
Prodeep Bose
Prodeep Bose
Executive Vice President, Groth and Innovation - THE BLOC
Jim Delash
Jim Delash
Multichannel Marketing Director - GSK
Zoe Dunn
Zoe Dunn
Principal - HALE ADVISORS
Lisa Flaiz
Lisa Flaiz
Director, Engagement Lead, WW Clinical Trials - BRISTOL MYERS SQUIBB
Pallavi Garg
Pallavi Garg
Vice President, Head of U.S. Marketing - TAKEDA
Christy Gaughan
Christy Gaughan
Vice President, Head of Global Insights and Digital Engagements - ROCHE
Shwen Gwee
Shwen Gwee
Vice President and Head of Global Digital Strategy - BRISTOL MYERS SQUIBB
Angela Horstmann
Angela Horstmann
Marketing Launch Lead, Immunology - ASTRAZENECA
Kevin Hsieh
Kevin Hsieh
Service Lead, Web and Mobile - GENENTECH
Hans Kaspersetz
Hans Kaspersetz
CEO - ARTERIC
Morris Kimble
Morris Kimble
Brand Manager, HCP Marketing – Digital - ELI LILLY
Jennifer Klein
Jennifer Klein
Senior Director, Global Commercial Digital Innovation - ASTRAZENECA
Matthew Lasmanis
Matthew Lasmanis
Chief Technology and Innovation Officer - SAGE THERAPEUTICS
John Lineen
John Lineen
Lead, Worldwide Engagement and Channel Planning (CV/IM) - BRISTOL MYERS SQUIBB
Lucian Marcinczyk
Lucian Marcinczyk
Executive Director, Head Worldwide Omni Channel Experience - BRISTOL MYERS SQUIBB
Lars Merk
Lars Merk
Senior Director, Global Commercial Digital and Innovation - ASTRAZENECA
Paul Murasko
Paul Murasko
Senior Director, Head of Digital Customer Interaction for North America - IPSEN
Trish Myers
Trish Myers
Senior Director, Lilly USA IT - ELI LILLY
Lauren Netolicky
Lauren Netolicky
Vice President, Business Development - WEGO HEALTH
Jeremy Pincus
Jeremy Pincus
Global Head of Digital Marketing Technologies and Platforms - GSK
Kim Mace Plumly
Kim Mace Plumly
Senior Director, Patient Experience - GSK
Lina Polimeni
Lina Polimeni
Chief Media Officer - ELI LILLY
Alison Reichert
Alison Reichert
Head, Digital and Omnichannel Marketing, US Oncology - TAKEDA
Michael Rowbotham
Michael Rowbotham
Digital Strategy Lead for Xeljanz Franchise, Director MCM - PFIZER
Mike Ruta
Mike Ruta
Director, Oncology Consumer Marketing - GSK
D.J. Sethares
D.J. Sethares
Senior Director, Global Marketing - VIIV HEALTHCARE
Diana Stoll
Diana Stoll
Head of Trustworthy Artificial Intelligence - Bayer
Stefanie Wagner
Stefanie Wagner
Brand Manager, Oncology - Eli Lilly
Amy Welsh
Amy Welsh
Vice President of Marketing - AGILE THERAPEUTICS
Alison Woo
Alison Woo
Head of Content and Editorial, Scientific Communications and Innovation - GSK
Francesca Wuttke
Francesca Wuttke
Chief Digital Officer - ALMIRALL

REASONS TO ATTEND

✔ Amplify digital at a critical time – identifying what the triggers for ‘must do’ changes, and assessing if these are these connected to true long lasting digital transformation

✔ Examining COVID forced acceptance of Omnichannel marketing importance: where do CX and MCM groups need to channel their energy and what elements to prioritize to deliver a consistent experience of your brand

✔ Analyze content consumption habits and behaviors of HCPs to develop your content and engagement strategy

✔ Scaling video content – keeping the authenticity; examples of good stories that make for great content and pull the story forward to capture emotion

✔ Quantify the right multichannel mix to select the right channel for the corresponding campaign

✔ Optimize your patient journey and adherence as a marketing aid – how ‘how to’ and ‘why’ build as patients continue to increase levels of expectation on access and reach

✔ Build a successful performance measurement framework to better interpret your data and understand your goals within analytics

✔ Minimize data noise and digital health errors through smart use of data analytics and combining data sources

✔ Reimbursement: relocating reimbursement as part of the innovation process – understand the value proposition of tech and quantify the willingness to pay

✔ Evaluate if we have seen the promise of AI come to fruition in this current period of turbulence. Has it done the job that we thought it would?

✔ Develop a methodology of how to split personal and non-personal promotion

WHO SHOULD ATTEND

✔ SVPs
✔ VPs
✔ Directors
✔ Heads
✔ Managers from the pharmaceutical
✔ Biotechnology
✔ Medical Device Industries
✔ Marketing
✔ Digital Marketing
✔ Digital Strategy
✔ Integrated Marketing
✔ Multichannel Marketing

✔ Social Media
✔ Mobile Marketing
✔ eMarketing
✔ eBusiness
✔ Global Marketing
✔ Interactive Services

✔ Commercial Excellence
✔ Commercial Operations/ Capabilities
✔Innovation
✔ Patient Solutions
✔ Customer Interaction/ Engagement
✔ Customer Insights
✔ Field Force/SFE
✔ Brand Management
✔ Product Management
✔ Strategic Operations
✔ PR/Communications
✔ New Media
✔ Advertising and Promotions
✔ IT
✔ Clinical Innovation
✔ Medical Affairs
✔ Legal Counsel and MLR
✔ Compliance

THANK YOU TO OUR SPONSORS

THANK YOU TO OUR MEDIA PARTNERS

Interested in Sponsorship Opportunities?

If you are interested in promoting your services to our curated audience of senior decision makers, contact us: sponsorinfo@momentumevents.com.

TAILORED MEDICAL PHARMA INDUSTRY INITIATIVES

The medical pharma marketing industry, to date, has been an underserved community in networks, events and content. At Momentum Health, we are committed to developing not only virtual events – and live events once it is safe to do so – but creating value in non-traditional content creation, network expansion and professional development on a year round basis.

To that end we are developing a Thought Leadership Council to provide a framework for a year round think tank of industry experts across enterprises of all sizes and scale to influence and advance the medical phama/medtech community. This will build a foundation as a vehicle for ideation that is essentially designed by the industry, for the industry.

THOUGHT LEADERSHIP COUNCIL FOR MEDICAL PHARMA

The aim is to create a continuum of information sharing within a community of marketing experts. This will drive ongoing industry dialogue at a time where traditional face to face sales calls and meetings with customers are no longer possible with COVID-19. You can share and evaluate concepts and derive knowledge for yourself and your organization. Even when in-person meetings are safe to attend, we want to cultivate a community of industry experts that are dedicated to improving the state of play for pharma.
Unlike traditional advisory boards, the agenda isn’t driven with a particular event in mind. The value for each individual is in having a safe platform to share the challenges you are facing, the best practices that your peers utilized to overcome challenges, pivots made or just validating general trends you are seeing. Having an expert, peer-led sounding board/think tank that takes place quarterly will help to drive meaningful solutions and processes with real outcomes.

PHARMACEUTICAL COMPANIES

SOLUTION/TECHNOLOGY PROVIDER:

GROUP DISCOUNTS AVAILABLE!

Contact Gabby Robles at gabby@momentumevents.com to get more information.

Click here to view the cancellation/refund/transfer policy

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close